RESUMO
In patients with amyotrophic lateral sclerosis (ALS), disease symptoms and pathology typically spread in a predictable spatiotemporal pattern beginning at a focal site of onset and progressing along defined neuroanatomical tracts. Like other neurodegenerative diseases, ALS is characterized by the presence of protein aggregates in postmortem patient tissue. Cytoplasmic, ubiquitin-positive aggregates of TDP-43 are observed in approximately 97% of sporadic and familial ALS patients, while SOD1 inclusions are likely specific to cases of SOD1-ALS. Additionally, the most common subtype of familial ALS, caused by a hexanucleotide repeat expansion in the first intron of the C9orf72 gene (C9-ALS), is further characterized by the presence of aggregated dipeptide repeat proteins (DPRs). As we will describe, cell-to-cell propagation of these pathological proteins tightly correlates with the contiguous spread of disease. While TDP-43 and SOD1 are capable of seeding protein misfolding and aggregation in a prion-like manner, C9orf72 DPRs appear to induce (and transmit) a 'disease state' more generally. Multiple mechanisms of intercellular transport have been described for all of these proteins, including anterograde and retrograde axonal transport, extracellular vesicle secretion, and macropinocytosis. In addition to neuron-to-neuron transmission, transmission of pathological proteins occurs between neurons and glia. Given that the spread of ALS disease pathology corresponds with the spread of symptoms in patients, the various mechanisms by which ALS-associated protein aggregates propagate through the central nervous system should be closely examined.
Assuntos
Esclerose Lateral Amiotrófica , Humanos , Esclerose Lateral Amiotrófica/metabolismo , Superóxido Dismutase-1/metabolismo , Agregados Proteicos , Proteína C9orf72/genética , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismoRESUMO
Fluoroquinolone prophylaxis is indicated to prevent neutropenic fever in patients with acute leukemia. However, fluoroquinolone use has been associated with development of multi-drug-resistant Pseudomonas aeruginosa and extended spectrum ß-lactamase producing gram-negative bacilli. Due to a presumed risk of multi-drug resistance associated with fluoroquinolone prophylaxis, patients admitted to our hospital with neutropenic fever receive empiric carbapenem therapy until cultures are negative for 72 h or identification of an organism. Our study seeks to identify the incidence of multi-drug-resistant organism colonization and bacteremia among patients who receive fluoroquinolone prophylaxis and to evaluate duration of empiric carbapenem therapy. A retrospective review of adult patients with acute leukemia receiving a fluoroquinolone as outpatient infection prophylaxis, admitted to our tertiary cancer center for treatment of neutropenic fever was completed. Surveillance and blood cultures were reviewed for antibiotic resistance. Duration of empiric carbapenem therapy was reviewed. One hundred patients and 177 admissions for neutropenic fever were included. Six patients harbored a piperacillin-tazobactam-resistant organism found during routine surveillance. Among these patients, two bacteremias were identified, one of which was a piperacillin-tazobactam-resistant organism. Five bacteremias were identified among 83 patients with negative surveillance cultures. Among the bloodstream infections, five organisms isolated were fluoroquinolone resistant. No cefepime-resistant organism was isolated on surveillance or bloodstream cultures. Adherence to the institution guideline of narrowing antibiotics after 72 h of negative cultures occurred in only 13% of neutropenic fever cases. The average duration of carbapenem therapy in 177 neutropenic fever episodes was 4.4 days. Our findings show that among our patient population, there is a low risk of bacteremia with a piperacillin-tazobactam-resistant or cefepime-resistant organism. However, prompt de-escalation of carbapenem therapy needs to be reiterated within hospital practice.
Assuntos
Bacteriemia/etiologia , Cefalosporinas/efeitos adversos , Fluoroquinolonas/administração & dosagem , Leucemia/tratamento farmacológico , Ácido Penicilânico/análogos & derivados , Profilaxia Pós-Exposição/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/efeitos adversos , Bacteriemia/diagnóstico , Bacteriemia/epidemiologia , Cefepima , Farmacorresistência Bacteriana/efeitos dos fármacos , Feminino , Humanos , Leucemia/diagnóstico , Leucemia/epidemiologia , Masculino , Pessoa de Meia-Idade , Ácido Penicilânico/efeitos adversos , Piperacilina/efeitos adversos , Combinação Piperacilina e Tazobactam , Distribuição Aleatória , Estudos Retrospectivos , Fatores de Risco , Adulto JovemRESUMO
BACKGROUND: Estrogen deficiency increases body weight or total and central adiposity and decreases energy expenditure. Hypothalamic neuropeptide Y (NPY) expression is altered by estrogen deficiency in rodents, but the long-term consequences on energy homeostasis are unknown. OBJECTIVE: To investigate the role of NPY in the changes in energy expenditure and physical activity, as well as the associated changes in body weight and composition in response to short-term and long-term estrogen deficiency. DESIGN: Sham and ovariectomy (OVX) operations were performed at 8 weeks of age in wild-type (WT) and NPY(-/-) mice. Energy expenditure, physical activity, body composition and weight, as well as food intake were measured at 10-18 days (short-term) and 46-54 days (long-term) after OVX. RESULTS: OVX influences energy homeostasis differently at early compared with later time-points. At the early but not the late time point, OVX in WT mice reduced oxygen consumption and energy expenditure and tended to reduce resting metabolic rate. Interestingly, these effects of short-term estrogen deficiency were ablated by NPY deletion, with NPY(-/-) mice exhibiting significant increases in energy expenditure and resting metabolic rate. In addition to these hypermetabolic effects, OVX NPY(-/-) mice exhibited significantly lower body weight and whole-body fat mass relative to OVX WT controls at the short-term but not the long-term time point. Food intake and physical activity were unaltered by OVX, but NPY(-/-) mice exhibited significant reductions in these parameters relative to WT. CONCLUSION: The effects of estrogen deficiency to reduce energy metabolism are transient, and NPY is critical to this effect as well as the early OVX-induced obesity.
Assuntos
Estrogênios/deficiência , Hipotálamo/metabolismo , Neuropeptídeo Y/metabolismo , Tecido Adiposo/metabolismo , Análise de Variância , Animais , Western Blotting , Peso Corporal , Calorimetria , Ingestão de Alimentos , Metabolismo Energético , Estrogênios/metabolismo , Feminino , Homeostase , Camundongos , Ovariectomia , Condicionamento Físico AnimalRESUMO
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with an average age-of-onset of â¼60 years and is usually fatal within 2-5 years of diagnosis. Mouse models based upon single gene mutations do not recapitulate all ALS pathological features. Environmental insults may also contribute to ALS, and ß-N-methylamino-L-alanine (BMAA) is an environmental toxin linked with an increased risk of developing ALS. BMAA, along with cycasin, are hypothesized to be the cause of the Guam-ALS epicenter of the 1950s. We developed a multihit model based on low expression of a dominant familial ALS TDP-43 mutation (Q331K) and chronic low-dose BMAA exposure. Our two-hit mouse model displayed a motor phenotype absent from either lesion alone. By LC/MS analysis, free BMAA was confirmed at trace levels in brain, and were as high as 405 ng/mL (free) and 208 ng/mL (protein-bound) in liver. Elevated BMAA levels in liver were associated with dysregulation of the unfolded protein response (UPR) pathway. Our data represent initial steps towards an ALS mouse model resulting from combined genetic and environmental insult.
Assuntos
Diamino Aminoácidos , Esclerose Lateral Amiotrófica , Doenças Neurodegenerativas , Animais , Camundongos , Esclerose Lateral Amiotrófica/induzido quimicamente , Esclerose Lateral Amiotrófica/genética , Esclerose Lateral Amiotrófica/metabolismo , Doenças Neurodegenerativas/complicações , Neurônios Motores/patologia , Fenótipo , Diamino Aminoácidos/toxicidade , Diamino Aminoácidos/genética , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Modelos Animais de DoençasRESUMO
AIMS: Both the neuronal-derived neuropeptide Y (NPY) and the gut hormone peptide YY (PYY) have been implicated in the regulation of energy balance and glucose homeostasis. However, despite similar affinities for the same Y receptors, the co-ordinated actions of these two peptides in energy and glucose homeostasis remain largely unknown. METHODS: To investigate the mechanisms and possible interactions between PYY with NPY in the regulation of these processes, we utilized NPY/PYY single and double mutant mouse models and examined parameters of energy balance and glucose homeostasis. RESULTS: PYY(-/-) mice exhibited increased fasting-induced food intake, enhanced fasting and oral glucose-induced serum insulin levels, and an impaired insulin tolerance, - changes not observed in NPY(-/-) mice. Interestingly, whereas PYY deficiency-induced impairment in insulin tolerance remained in NPY(-/-) PYY(-/-) mice, effects of PYY deficiency on fasting-induced food intake and serum insulin concentrations at baseline and after the oral glucose bolus were absent in NPY(-/-) PYY(-/-) mice, suggesting that NPY signalling may be required for PYY's action on insulin secretion and fasting-induced hyperphagia. Moreover, NPY(-/-) PYY(-/-) , but not NPY(-/-) or PYY(-/-) mice had significantly decreased daily food intake, indicating interactive control by NPY and PYY on spontaneous food intake. Furthermore, both NPY(-/-) and PYY(-/-) mice showed significantly reduced respiratory exchange ratio during the light phase, with no additive effects observed in NPY(-/-) PYY(-/-) mice, indicating that NPY and PYY may regulate oxidative fuel selection via partly shared mechanisms. Overall, physical activity and energy expenditure, however, are not significantly altered by NPY and PYY single or double deficiencies. CONCLUSIONS: These findings show significant and diverse interactions between NPY and PYY signalling in the regulation of different aspects of energy balance and glucose homeostasis.
Assuntos
Tecido Adiposo/metabolismo , Neuropeptídeo Y/metabolismo , Peptídeo YY/metabolismo , Animais , Ingestão de Alimentos , Metabolismo Energético , Jejum/sangue , Teste de Tolerância a Glucose , Homeostase , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Atividade Motora , Neuropeptídeo Y/genética , Neuropeptídeo Y/farmacologia , Peptídeo YY/genética , Transdução de SinaisRESUMO
Adverse events linked to perturbations of cellular genes by vector insertion reported in gene therapy trials and animal models have prompted attempts to better understand the mechanisms directing viral vector integration. The integration profiles of vectors based on MLV, ASLV, SIV and HIV have all been shown to be non-random, and novel vectors with a safer integration pattern have been sought. Recently, we developed a producer cell line called CatPac that packages standard MoMLV vectors with feline leukemia virus (FeLV) gag, pol and env gene products. We now report the integration profile of this vector, asking if the FeLV integrase and capsid proteins could modify the MoMLV integration profile, potentially resulting in a less genotoxic pattern. We transduced rhesus macaque CD34+ hematopoietic progenitor cells with CatPac or standard MoMLV vectors, and determined their integration profile by LAM-PCR. We obtained 184 and 175 unique integration sites (ISs) respectively for CatPac and standard MoMLV vectors, and these were compared with 10 000 in silico-generated random IS. The integration profile for CatPac vector was similar to MoMLV and equally non-random, with a propensity for integration near transcription start sites and in highly dense gene regions. We found an IS for CatPac vector localized 715 nucleotides upstream of LMO-2, the gene involved in the acute lymphoblastic leukemia developed by X-SCID patients treated by gene therapy using MoMLV vectors. In conclusion, we found that replacement of MoMLV env, gag and pol gene products with FeLV did not alter the basic integration profile. Thus, there appears to be no safety advantage for this packaging system. However, considering the stability and efficacy of CatPac vectors, further development is warranted, using potentially safer vector backbones, for instance those with a SIN configuration.
Assuntos
Técnicas de Transferência de Genes/efeitos adversos , Vetores Genéticos/efeitos adversos , Células-Tronco Hematopoéticas/virologia , Integrases/genética , Vírus da Leucemia Felina/genética , Vírus da Leucemia Murina de Moloney/genética , Integração Viral , Animais , Capsídeo , Proteínas do Capsídeo/genética , Vírus da Leucemia Felina/metabolismo , Macaca mulatta , Transdução GenéticaRESUMO
OBJECTIVE: Neuropeptide Y and its Y receptors are important players in the regulation of energy homeostasis. However, while their functions in feeding regulation are well recognized, functions in other critical aspects of energy homeostasis are largely unknown. To investigate the function of Y1 receptors in the regulation of energy homeostasis, we examined energy expenditure, physical activity, body composition, oxidative fuel selection and mitochondrial oxidative capacity in germline Y1(-/-) mice as well as in a conditional Y1-receptor-knockdown model in which Y1 receptors were knocked down in peripheral tissues of adult mice. RESULTS: Germline Y1(-/-) mice of both genders not only exhibit a decreased respiratory exchange ratio, indicative of increased lipid oxidation, but interestingly also develop late-onset obesity. However, the increased lipid oxidation is a primary effect of Y1 deletion rather than secondary to increased adiposity, as young Y1(-/-) mice are lean and show the same effect. The mechanism behind this is likely because of increased liver and muscle protein levels of carnitine palmitoyltransferase-1 (CPT-1) and maximal activity of key enzymes involved in beta-oxidation; beta-hydroxyacyl CoA dehydrogenase (betaHAD) and medium-chain acyl-CoA dehydrogenase (MCAD), leading to increased mitochondrial capacity for fatty acid transport and oxidation. These effects are controlled by peripheral Y1-receptor signalling, as adult-onset conditional Y1 knockdown in peripheral tissues also leads to increased lipid oxidation, liver CPT-1 levels and betaHAD activity. Importantly, these mice are resistant to diet-induced obesity. CONCLUSIONS: This work shows the primary function of peripheral Y1 receptors in the regulation of oxidative fuel selection and adiposity, opening up new avenues for anti-obesity treatments by targeting energy utilization in peripheral tissues rather than suppressing appetite by central effects.
Assuntos
Metabolismo Energético/fisiologia , Ácidos Graxos/metabolismo , Neuropeptídeo Y/metabolismo , Obesidade/metabolismo , Receptores de Neuropeptídeo Y/fisiologia , 3-Hidroxiacil-CoA Desidrogenases/metabolismo , Acil-CoA Desidrogenase/metabolismo , Animais , Composição Corporal , Carnitina O-Palmitoiltransferase/metabolismo , Feminino , Homeostase/fisiologia , Masculino , Camundongos , Mitocôndrias/metabolismo , Atividade Motora , Obesidade/fisiopatologia , OxirreduçãoRESUMO
AIMS: Energy homeostasis is regulated by a complex interaction of molecules and pathways, and new antiobesity treatments are likely to require multiple pharmacological targeting of anorexigenic or orexigenic pathways to achieve effective loss of excess body weight and adiposity. Cannabinoids, acting via the cannabinoid-1 (CB1) receptor, and neuropeptide Y (NPY) are important modulators of feeding behaviour, energy metabolism and body composition. We investigated the interaction of CB1 and NPY in the regulation of energy homeostasis, hypothesizing that dual blockade of CB1 and NPY signalling will induce greater weight and/or fat loss than that induced by single blockade of either system alone. METHODS: We studied the effects of the CB1 antagonist Rimonabant on food intake, body weight, body composition, energy metabolism and bone physiology in wild-type (WT) and NPY knockout (NPY(-/-)) mice. Rimonabant was administered orally at 10 mg/kg body weight twice per day for 3 weeks. Oral Rimonabant was delivered voluntarily to mice via a novel method enabling studies to be carried out in the absence of gavage-induced stress. RESULTS: Mice with dual blockade of CB1 and NPY signalling (Rimonabant-treated NPY(-/-) mice) exhibited greater reductions in body weight and adiposity than mice with single blockade of either system alone (Rimonabant-treated WT or vehicle-treated NPY(-/-) mice). These changes occurred without loss of lean tissue mass or bone mass. Furthermore, Rimonabant-treated NPY(-/-) mice showed a lower respiratory exchange ratio than that seen in Rimonabant-treated WT or vehicle-treated NPY(-/-) mice, suggesting that this additive effect of dual blockade of CB1 and NPY involves promotion of lipid oxidation. On the other hand, energy expenditure and physical activity were comparable amongst all treatment groups. Interestingly, Rimonabant similarly and transiently reduced spontaneous and fasting-induced food intake in WT and NPY(-/-) mice in the first hour after administration only, suggesting independent regulation of feeding by CB1 and NPY signalling. In contrast, Rimonabant increased serum corticosterone levels in WT mice, but this effect was not seen in NPY(-/-) mice, indicating that NPY signalling may be required for effects of CB1 on the hypothalamo-pituitary-adrenal axis. CONCLUSIONS: Dual blockade of CB1 and NPY signalling leads to additive reductions in body weight and adiposity without concomitant loss of lean body mass or bone mass. An additive increase in lipid oxidation in dual CB1 and NPY blockade may contribute to the effect on adiposity. These findings open new avenues for more effective treatment of obesity via dual pharmacological manipulations of the CB1 and NPY systems.
Assuntos
Ingestão de Alimentos/efeitos dos fármacos , Neuropeptídeo Y/efeitos dos fármacos , Obesidade/tratamento farmacológico , Piperidinas/antagonistas & inibidores , Pirazóis/antagonistas & inibidores , Receptor CB1 de Canabinoide/antagonistas & inibidores , Receptores de Neuropeptídeo Y/efeitos dos fármacos , Animais , Composição Corporal , Metabolismo Energético/efeitos dos fármacos , Homeostase/fisiologia , Camundongos , Neuropeptídeo Y/metabolismo , Obesidade/metabolismo , Oxirredução , Piperidinas/administração & dosagem , Pirazóis/administração & dosagem , Receptor CB1 de Canabinoide/administração & dosagem , RimonabantoRESUMO
New (1-x)Bi0.5Na0.5TiO3 + xCaFeO3-δ solid solution compounds were fabricated using a sol-gel method. The CaFeO3-δ materials were mixed into host Bi0.5Na0.5TiO3 materials to form a solid solution that exhibited similar crystal symmetry to those of Bi0.5Na0.5TiO3 phases. The random distribution of Ca and Fe cations in the Bi0.5Na0.5TiO3 crystals resulted in a distorted structure. The optical band gaps decreased from 3.11 eV for the pure Bi0.5Na0.5TiO3 samples to 2.34 eV for the 9 mol% CaFeO3-δ-modified Bi0.5Na0.5TiO3 samples. Moreover, the Bi0.5Na0.5TiO3 samples exhibited weak photoluminescence because of the intrinsic defects and suppressed photoluminescence with increasing CaFeO3-δ concentration. Experimental and theoretical studies via density functional theory calculations showed that pure Bi0.5Na0.5TiO3 exhibited intrinsic ferromagnetism, which is associated with the possible presence of Bi, Na, and Ti vacancies and Ti3+-defect states. Further studies showed that such an induced magnetism by intrinsic defects can also be enhanced effectively with CaFeO3-δ addition. This study provides a basis for understanding the role of secondary phase as a solid solution in Bi0.5Na0.5TiO3 to facilitate the development of lead-free ferroelectric materials.
RESUMO
The main pepsinogen from the mucosa of the shark, Centroscymnus coelolepis, has been purified and characterized. This zymogen, the most abundant protein in terms of quantity and activity (yield 72%), is a homogeneous monomer of molecular weight 42+/-0.7 kDa, as determined by electrophoresis. The aspartyl proteinase nature of this enzyme was confirmed by the considerable inhibition by pepstatin. Its specificity as to the oxidized B-chain of bovine insulin was determined using electrospray ionization mass spectrometry (ESI-MS) coupled with reversed phase high pressure liquid chromatography (RP-HPLC). The 15-16 Leu-Tyr bond was rapidly cleaved in this substrate, followed by the 24-25 Phe-Phe, 25-26 Phe-Tyr, and 11-12 Leu-Val bonds.
Assuntos
Mucosa Gástrica/enzimologia , Pepsinogênio A/química , Pepsinogênio A/isolamento & purificação , Sequência de Aminoácidos , Animais , Autólise , Catálise , Endopeptidases/metabolismo , Insulina/metabolismo , Dados de Sequência Molecular , Pepsinogênio A/metabolismo , Análise de Sequência , Tubarões , Especificidade por SubstratoRESUMO
The biological characteristics of isolates of T. evansi collected from buffalo in different provinces in North Vietnam was determined in terms of their sensitivity to drugs currently used in the treatment of trypanosomosis. Five isolates were collected from buffalo, cloned and then tested against Trypamidium, Samorine, Naganol and Veriben. All isolates were sensitive to Naganol and Veriben. An isolate from a buffalo in Ha bac province (Hb1) was the least sensitive with trypamidium at a CD80 > 128 mg/kg, more than 8 times the CD 100 of the remaining isolates (16 mg/kg). An antigen-detection enzyme immunoassay (Ag-ELISA) based on a T. evansi-specific monoclonal antibody was evaluated for its ability to detect infections with T. evansi in buffalo. The sensitivity of the Ag-ELISA was 63% and the specificity 75%. The positive predictive value of this assay was too low to allow identification of individual infected animals on the results of a single test in the districts investigated. For definitive diagnosis, a serial testing protocol was used, where a more specific test, the card agglutination test (CATT) was used initially and any positive samples was then checked by the Ag-ELISA.
Assuntos
Búfalos , Tripanossomicidas/toxicidade , Trypanosoma/efeitos dos fármacos , Tripanossomíase/veterinária , Testes de Aglutinação , Animais , Anticorpos Antiprotozoários/sangue , Avaliação Pré-Clínica de Medicamentos/métodos , Ensaio de Imunoadsorção Enzimática , Camundongos , Fenantridinas/toxicidade , Valor Preditivo dos Testes , Reprodutibilidade dos Testes , Estações do Ano , Suramina/toxicidade , Tripanossomicidas/uso terapêutico , Tripanossomíase/diagnóstico , Tripanossomíase/tratamento farmacológico , VietnãRESUMO
Adrenarche is most commonly defined as a prepubertal increase in circulating adrenal androgens, dehydroepiandrosterone (DHEA) and its sulfo-conjugate (DHEAS). This event is thought to have evolved in humans and some great apes but not in Old World monkeys, perhaps to promote brain development. Whether adrenarche represents a shared, derived developmental event in humans and our closest relatives, adrenal androgen secretion (and its regulation) is of considerable clinical interest. Specifically, adrenal androgens play a significant role in the pathophysiology of polycystic ovarian disease and breast and prostate cancers. Understanding the development of androgen secretion by the human adrenal cortex and identifying a suitable model for its study are therefore of central importance for clinical and evolutionary concerns. This review will examine the evidence for adrenarche in nonhuman primates (NHP) and suggest that a broader definition of this developmental event is needed, including morphological, biochemical, and endocrine criteria. Using such a definition, evidence from recent studies suggests that adrenarche evolved in Old World primates but spans a relatively brief period early in development compared with humans and some great apes. This emphasizes the need for frequent longitudinal sampling in evaluating developmental changes in adrenal androgen secretion as well as the tenuous nature of existing evidence of adrenarche in some species among the great apes. Central to an understanding of the regulation of adrenal androgen production in humans is the recognition of the complex nature of adrenarche and the need for more carefully conducted comparative studies and a broader definition in order to promote investigation among NHP in particular.
Assuntos
Adrenarca/fisiologia , Primatas/fisiologia , Terminologia como Assunto , Adrenarca/sangue , Adrenarca/genética , Adrenarca/metabolismo , Animais , Evolução Biológica , Endocrinologia/métodos , Endocrinologia/tendências , Humanos , Estudos Longitudinais , Primatas/classificação , Primatas/genética , Primatas/metabolismo , Projetos de PesquisaRESUMO
Adrenarche, defined as a prepubertal increase in adrenal androgen secretion resulting from zona reticularis (ZR) maturation, is thought to occur only in humans and some Great Apes. In the rhesus macaque, studies of circulating dehydroepiandrosterone (DHEA) or its sulpho-conjugate (DHEAS) have failed to demonstrate a prepubertal rise typical of human adrenarche, but available data are cross-sectional and include few neonatal or early infant samples. However, ZR maturation is complete in rhesus infants by 3 months of age based on morphological and biochemical analyses. Furthermore, preliminary longitudinal studies from birth through infancy of castrated males, and intact males and females, suggests for the first time that there is a transient, prepubertal elevation of adrenal androgen in rhesus macaques. Serum DHEAS concentration increased, peaking between 6 and 8 weeks of age in castrate males, and intact males and females, then declined. These longitudinal profiles add endocrinological support to the morphological and biochemical evidence that adrenarche occurs in a narrow developmental window in infant rhesus macaques. Adrenarche in any species should be defined only after careful longitudinal hormone analysis have been conducted in stages of development that are suggested by morphological and biochemical evidence of ZR maturation.
Assuntos
Glândulas Suprarrenais/metabolismo , Adrenarca/fisiologia , Androgênios/metabolismo , Macaca mulatta/fisiologia , Modelos Animais , Animais , HumanosRESUMO
As the ultimate electron acceptor in oxidative phosphorylation, oxygen plays a critical role in metabolism. When oxygen levels drop, heterodimeric hypoxia-inducible factor (Hif) transcription factors become active and facilitate adaptation to hypoxia. Hif regulation by oxygen requires the protein von Hippel-Lindau (pVhl) and pVhl disruption results in constitutive Hif activation. The liver is a critical organ for metabolic homeostasis, and Vhl inactivation in hepatocytes results in a Hif-dependent shortening in life span. While albumin-Cre;Vhl(F/F) mice develop hepatic steatosis and impaired fatty acid oxidation, the variable penetrance and unpredictable life expectancy has made the cause of death elusive. Using a system in which Vhl is acutely disrupted and a combination of ex vivo liver perfusion studies and in vivo oxygen measurements, we demonstrate that Vhl is essential for mitochondrial respiration in vivo. Adenovirus-Cre mediated acute Vhl disruption in the liver caused death within days. Deprived of pVhl, livers accumulated tryglicerides and circulating ketone and glucose levels dropped. The phenotype was reminiscent of inborn defects in fatty acid oxidation and of fasted PPARα-deficient mice and while death was unaffected by pharmacologic PPARα activation, it was delayed by glucose administration. Ex vivo liver perfusion analyses and acylcarnitine profiles showed mitochondrial impairment and a profound inhibition of liver ketone and glucose production. By contrast, other mitochondrial functions, such as ureagenesis, were unaffected. Oxygen consumption studies revealed a marked suppression of mitochondrial respiration, which, as determined by magnetic resonance oximetry in live mice, was accompanied by a corresponding increase in liver pO(2). Importantly, simultaneous inactivation of Hif-1ß suppressed liver steatosis and rescued the mice from death. These data demonstrate that constitutive Hif activation in mice is sufficient to suppress mitochondrial respiration in vivo and that no other pathway exists in the liver that can allow oxygen utilization when Hif is active precluding thereby metabolic collapse.
Assuntos
Hipoglicemia/patologia , Hipóxia/metabolismo , Cetonas/sangue , Fígado/metabolismo , Oxigênio/metabolismo , Transdução de Sinais , Animais , Gluconeogênese , Hipoglicemia/metabolismo , Camundongos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Proteína Supressora de Tumor Von Hippel-Lindau/genética , Proteína Supressora de Tumor Von Hippel-Lindau/fisiologiaRESUMO
A new perturbation analysis of the first negative system B(2)Σ(u)(+) ? X(2)Σ(g)(+) of the (14)N(2)(+) ion is performed based on spectra excited both at low and high temperatures by the use of either a hollow-cathode or a Pointolite lamp. Preliminary results are given for a deperturbation of the B(2)Σ(u)(+) (ν = 0, ν = 1) levels. Deperturbed molecular constants and parameters that describe the B(2)Σ(u)(+) ~ A(2)∏(u) interaction are derived.
RESUMO
We present an algorithm for fast and reliable extraction of page-formatted binary digital data. The advantages of the algorithm include a low raw bit-error rate, fast extraction speed, the use of a simple and density-efficient coding scheme, and large tolerance to a change of the signal-to-noise ratio. We used this algorithm to analyze shot-noise-limited binary data that had large interpage and intrapage intensity variations and obtained an improvement in the bit-error rate of 3-4 orders of magnitude compared with that in a single-threshold-detection scheme. Implications of our results for the development of high-speed, high-density holographic memories are discussed.